Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). (Q35904572)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 December 2011

Language	Label	Description	Also known as
English	Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).	scientific article published on 25 December 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Charles M. Perou

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

object named as

Marc E Lenburg

10

0 references

Olufunmilayo Olopade

22

object named as

Olufunmilayo I Olopade

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1

object named as

Laura J Esserman

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Constance D Lehman

20

object named as

Constance Lehman

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

23

object named as

Hope S Rugo

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

21

object named as

Minetta C Liu

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

8

object named as

Joe W Gray

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

4

object named as

Christina Yau

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

Donald A Berry

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Maggie C U Cheang

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Lisa Carey

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Angela DeMichele

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Kathleen Conway-Dorsey

9

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Meredith B Buxton

11

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Sarah E Davis

12

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Laura J van't Veer

13

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Clifford Hudis

14

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Koei Chin

15

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Denise Wolf

16

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Helen Krontiras

17

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Leslie Montgomery

18

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Debu Tripathy

19

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

John T Carpenter

24

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Chad Livasy

25

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Lynn Dressler

26

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

David Chhieng

27

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Baljit Singh

28

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Carolyn Mies

29

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Joseph Rabban

30

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Yunni-Yi Chen

31

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Dilip Giri

32

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Alfred Au

33

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Nola Hylton

34

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

I-SPY 1 TRIAL Investigators

35

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

25 December 2011

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

132

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1049-1062

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Biologic markers determine both the risk and the timing of recurrence in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Cell-matrix interactions in mammary gland development and breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Supervised risk predictor of breast cancer based on intrinsic subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Clinical application of the 70-gene profile: the MINDACT trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Gene expression patterns associated with p53 status in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Converting a breast cancer microarray signature into a high-throughput diagnostic test.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Molecular inversion probe analysis of gene copy alterations reveals distinct categories of colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

The molecular portraits of breast tumors are conserved across microarray platforms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Circular binary segmentation for the analysis of array-based DNA copy number data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Multiplexed genotyping with sequence-tagged molecular inversion probes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Prevalence and spectrum of p53 mutations associated with smoking in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

11 July 2018

The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

24 September 2018

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332388

24 September 2018

R: A Language for Data Analysis and Graphics

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1895-2

21 January 2018

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://pubmed.ncbi.nlm.nih.gov/22198468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22198468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27

1 reference

https://pubmed.ncbi.nlm.nih.gov/22198468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TAILORx: trial assigning individualized options for treatment (Rx)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22198468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system

1 reference

https://pubmed.ncbi.nlm.nih.gov/22198468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Hazards of Endpoints

1 reference

https://pubmed.ncbi.nlm.nih.gov/22198468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10549-011-1895-2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35904572&oldid=2264931132"